BriaCell Therapeutics Cor...

NASDAQ: BCTX · Real-Time Price · USD
0.74
0.00 (0.14%)
At close: Aug 15, 2025, 3:59 PM
0.72
-2.70%
After-hours: Aug 15, 2025, 07:39 PM EDT

BriaCell Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is August - July.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jul 31, 2024 Jul 31, 2023 Jul 31, 2022 Jul 31, 2021
Net Income
-4.93M -20.3M -26.84M -428.33K
Depreciation & Amortization
82.58K 15.27K 15.27K 15.26K
Stock-Based Compensation
1.8M 2.19M 3.07M 1.97M
Other Working Capital
1.74M -4.19M -640.46K -876.45K
Other Non-Cash Items
-28.13M -2.12M 11.66M 1.84M
Deferred Income Tax
n/a n/a n/a -8.86M
Change in Working Capital
7.05M -3.53M -391.29K -2.28M
Operating Cash Flow
-24.13M -23.74M -12.48M -7.75M
Capital Expenditures
-456.8K n/a n/a n/a
Cash Acquisitions
-225K n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-7.15K n/a n/a n/a
Investing Cash Flow
-681.8K n/a n/a n/a
Debt Repayment
n/a n/a n/a -330.4K
Common Stock Repurchased
n/a -47.29K -13.03M n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 1.59K 6.43M 13.7M
Financial Cash Flow
4.42M 3.95M -3.74M 65M
Net Cash Flow
-20.39M -19.79M -16.23M 57.25M
Free Cash Flow
-24.58M -23.74M -12.48M -7.75M